Clinical research progress of intravenous thrombolysis of urokinase and alteplase in the treatment of a-cute cerebral infarction / 心血管康复医学杂志

ABSTRACT

Acute cerebral infarction(ACI)is the most common type of stroke.Intravenous thrombolysis is the most effective treatment measure for ACI,which can reopen the occluded vessels,save the ischemic penumbra and im-prove the prognosis.Urokinase and alteplase,as the first-and second-generation drug of intravenous thrombolys-is,have been widely used in clinical practice,each with its own advantages and disadvantages.The present article makes a brief review on the clinical research progress of intravenous thrombolysis of urokinase and alteplase in the treatment of ACI.